SosNalghranyanMDMD

Internal Medicine • Brooklyn, NY

Hospital Medicine/Hospitalist, Hematology/Oncology

Primary Care Physician/Hospitalist

Join to view full profile

Dr. Nalghranyan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Nalghranyan's full profile

Already have an account?

Office
1 Brookdale Plz
Brooklyn, NY 11212
Phone+1 718-240-5000
Is this information wrong?

Education & Training

One Brooklyn Health System/Brookdale University Hospital and Medical CenterFellowship, Hematology and Medical Oncology, 2019 - 2022
St John's Episcopal Hospital-South ShoreResidency, Internal Medicine, 2014 - 2017
Yerevan State Medical UniversityClass of 2006

Certifications & Licensure

FL State Medical License 2022 - 2026
MI State Medical License 2023 - 2026
NY State Medical License 2018 - 2026
CA State Medical License 2016 - 2026
AR State Medical License 2018 - 2019
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Treatment-Refractory, Primary Immune Thrombocytopenic Purpura in a Patient with Celiac Disease.
Beka Aroshidze, Sos Nalghranyan, Gregory Gotlieb, Burak Erdinc, Alok Aggarwal, Cherif El Younis, Boris Avezbakiyav> ;The American Journal of Case Reports. 2021 Oct 10
19 citations
The combination of venetoclax, daratumumab and dexamethasone for the treatment of refractory primary plasma cell leukemia.
Sos Nalghranyan, Amrit P. Singh, Carolina Schinke> ;American Journal of Hematology. 2020 Feb 1

Hospital Affiliations

Lower Keys Medical CenterKey West, Florida
Fishermen's HospitalMarathon, Florida
MyMichigan Medical Center MidlandMidland, Michigan
MyMichigan Medical Center AlpenaAlpena, Michigan